➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Express Scripts
Medtronic
McKesson
Dow

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Litigation Details for Centripetal Networks, Inc. v. Cisco Systems, Inc. (E.D. Va. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Centripetal Networks, Inc. v. Cisco Systems, Inc. (E.D. Va. 2018)

Docket   Start Trial Date Filed 2018-02-13
Court District Court, E.D. Virginia Date Terminated
Cause 35:271 Patent Infringement Assigned To Henry Coke Morgan Jr.
Jury Demand Both Referred To Lawrence Richard Leonard
Patents 10,004,686; 10,004,792; 10,005,779; 10,005,783; 10,005,847; 10,007,766; 10,010,260; 10,010,777; 10,011,857; 10,016,404; 10,016,407; 10,016,435; 10,016,451; 10,017,712; 10,017,775; 10,022,451; 10,023,917; 10,028,858; 10,028,962; 10,028,995; 10,030,059; 10,035,766; 10,039,754; 10,039,758; 10,039,779; 10,039,780; 10,039,804; 10,040,783; 10,040,857; 10,115,021; 10,124,014; 10,124,040; 10,124,132; 10,130,591; 10,130,686; 10,130,697; 10,132,804; 10,137,104; 10,137,127; 10,137,193; 10,137,202; 10,149,893; 10,149,901; 10,154,856; 10,154,987; 10,154,990; 10,154,998; 10,202,357; 10,202,419; 10,206,893; 10,206,939; 10,253,077; 10,253,132; 10,300,010; 10,300,016; 10,300,039; 10,357,032; 10,357,540; 10,357,550; 10,391,094; 10,391,154; 10,406,006; 10,406,202; 10,413,505; 10,435,404; 10,471,023; 10,471,067; 10,478,505; 10,495,650; 10,525,022; 10,525,033; 10,525,052; 10,525,104; 10,525,115; 10,525,124; 10,525,205; 10,526,407; 10,526,631; 10,526,668; 10,545,135; 10,550,193; 10,550,357; 10,556,010; 10,556,024; 10,556,037; 10,557,115; 10,557,862; 10,563,271; 10,569,034; 6,010,726; 6,015,832; 6,016,871; 6,019,980; 6,029,874; 6,030,775; 6,030,778; 6,039,998; 6,050,697; 6,059,246; 6,124,495; 6,130,248; 6,132,793; 6,248,032; 6,302,556; 6,413,176; 6,413,776; 6,435,989; 6,494,783; 6,495,157; 6,521,815; 6,525,154; 6,530,202; 6,531,824; 6,545,040; 6,569,444; 6,569,480; 6,624,124; 6,686,170; 6,756,520; 6,756,524; 6,758,975; 6,767,901; 6,774,104; 6,783,471; 6,787,524; 6,787,531; 6,794,137; 6,811,794; 6,811,824; 6,824,822; 6,824,975; 6,830,253; 6,830,520; 6,830,521; 6,830,766; 6,858,618; 6,858,650; 6,861,435; 6,866,866; 6,893,253; 6,939,540; 6,984,518; 6,987,094; 6,994,847; 6,998,391; 7,008,524; 7,014,861; 7,014,990; 7,018,668; 7,018,806; 7,022,330; 7,030,149; 7,033,998; 7,037,527; 7,037,917; 7,052,419; 7,059,862; 7,067,124; 7,067,551; 7,067,712; 7,115,408; 7,132,408; 7,132,554; 7,135,618; 7,147,067; 7,147,779; 7,149,631; 7,154,029; 7,176,026; 7,202,031; 7,205,302; 7,255,990; 7,300,794; 7,388,029; 7,391,021; 7,408,018; 7,408,024; 7,419,983; 7,419,996; 7,445,775; 7,480,775; 7,494,530; 7,494,815; 7,495,030; 7,520,866; 7,524,831; 7,527,787; 7,527,815; 7,531,518; 7,531,530; 7,550,433; 7,550,445; 7,560,271; 7,560,444; 7,560,445; 7,563,871; 7,569,554; 7,618,996; 7,619,004; 7,619,032; 7,638,552; 7,674,776; 7,674,800; 7,686,786; 7,713,255; 7,714,006; 7,754,271; 7,754,861; 7,758,863; 7,758,886; 7,767,406; 7,767,445; 7,767,669; 7,767,689; 7,767,806; 7,776,618; 7,777,028; 7,780,984; 7,780,987; 7,785,779; 7,785,780; 7,785,871; 7,786,052; 7,794,697; 7,794,998; 7,806,777; 7,811,560; 7,811,618; 7,811,782; 7,816,404; 7,824,726; 7,824,774; 7,847,486; 7,856,779; 7,858,300; 7,862,832; 7,862,995; 7,871,631; 7,871,806; 7,871,988; 7,886,697; 7,893,035; 7,939,063; 7,939,518; 7,939,540; 7,939,714; 7,988,001; 7,988,994; 7,988,998; 7,989,205; 7,989,494; 7,994,135; 8,003,792; 8,007,793; 8,007,794; 8,007,806; 8,007,830; 8,017,557; 8,017,758; 8,017,980; 8,019,551; 8,029,391; 8,029,783; 8,030,067; 8,030,545; 8,034,366; 8,034,618; 8,034,832; 8,034,994; 8,034,997; 8,039,451; 8,039,494; 8,050,406; 8,052,987; 8,063,029; 8,063,031; 8,067,025; 8,067,451; 8,067,551; 8,067,668; 8,132,712; 8,137,994; 8,147,866; 8,193,176; 8,205,624; 8,215,300; 8,236,752; 8,236,804; 8,246,495; 8,246,962; 8,246,979; 8,246,980; 8,246,989; 8,287,847; 8,330,006; 8,357,147; 8,357,697; 8,366,866; 8,404,215; 8,404,811; 8,419,847; 8,435,540; 8,435,545; 8,435,551; 8,435,554; 8,435,767; 8,444,988; 8,445,018; 8,445,524; 8,445,526; 8,445,650; 8,471,025; 8,480,631; 8,518,404; 8,518,406; 8,518,886; 8,518,987; 8,524,260; 8,524,777; 8,524,979; 8,525,104; 8,529,939; 8,530,176; 8,530,668; 8,545,830; 8,545,893; 8,551,520; 8,551,521; 8,551,980; 8,557,551; 8,557,783; 8,557,806; 8,557,831; 8,563,008; 8,563,027; 8,563,033; 8,563,521; 8,563,527; 8,563,563; 8,563,689; 8,569,015; 8,569,017; 8,569,021; 8,569,471; 8,569,560; 8,591,357; 8,591,668; 8,591,983; 8,618,135; 8,657,804; 8,674,176; 8,686,026; 8,686,034; 8,686,170; 8,697,031; 8,697,067; 8,697,193; 8,697,618; 8,697,686; 8,697,847; 8,714,149; 8,722,650; 8,722,657; 8,754,011; 8,758,726; 8,758,816; 8,758,998; 8,778,302; 8,778,366; 8,778,620; 8,778,962; 8,778,997; 8,779,004; 8,791,127; 8,791,154; 8,815,246; 8,815,816; 8,816,863; 8,822,012; 8,822,176; 8,822,407; 8,822,668; 8,822,712; 8,847,766; 8,858,939; 8,858,987; 8,858,996; 8,870,847; 8,871,203; 8,871,527; 8,871,779; 8,871,783; 8,871,791; 8,893,995; 8,939,962; 8,962,010; 8,962,012; 8,962,028; 8,962,034; 8,962,591; 8,962,804; 8,975,034; 8,975,471; 8,979,271; 8,980,248; 8,980,300; 8,980,319; 8,980,569; 8,980,822; 8,980,901; 8,986,304; 8,986,686; 8,986,939; 8,986,996; 8,987,554; 8,998,518; 8,998,754; 8,998,793; 9,005,619; 9,011,391; 9,011,917; 9,012,154; 9,012,518; 9,016,147; 9,017,726; 9,023,391; 9,023,783; 9,023,787; 9,027,319; 9,029,321; 9,029,357; 9,033,830; 9,034,300; 9,034,391; 9,034,822; 9,035,132; 9,050,248; 9,050,302; 9,067,989; 9,067,990; 9,115,137; 9,115,407; 9,127,013; 9,132,003; 9,132,202; 9,149,530; 9,149,697; 9,193,782; 9,193,787; 9,193,791; 9,206,135; 9,206,248; 9,206,408; 9,248,115; 9,248,191; 9,260,494; 9,271,866; 9,271,975; 9,271,990; 9,302,002; 9,321,754; 9,321,778; 9,408,823; 9,408,858; 9,408,893; 9,408,917; 9,408,979; 9,433,619; 9,433,668; 9,435,794; 9,435,811; 9,518,115; 9,518,130; 9,518,203; 9,526,725; 9,526,726; 9,526,791; 9,527,857; 9,527,858; 9,540,433; 9,540,435; 9,545,435; 9,550,780; 9,550,975; 9,550,983; 9,550,997; 9,551,009; 9,551,033; 9,556,260; 9,569,321; 9,631,191; 9,631,193; 9,638,697; 9,650,433; 9,650,444; 9,669,008; 9,669,009; 9,669,023; 9,669,024; 9,669,026; 9,669,094; 9,689,015; 9,713,625; 9,725,444; 9,726,669; 9,752,193; 9,756,871; 9,757,552; 9,758,524; 9,782,406; 9,782,480; 9,782,550; 9,782,551; 9,791,451; 9,815,886; 9,856,480; 9,861,631; 9,861,870; 9,862,686; 9,862,767; 9,902,714; 9,962,400; 9,975,021; 9,980,983; 9,987,271; 9,987,330; 9,987,357; 9,988,406; 9,994,525; 9,994,550; 9,994,858
Link to Docket External link to docket
Small Molecule Drugs cited in Centripetal Networks, Inc. v. Cisco Systems, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Centripetal Networks, Inc. v. Cisco Systems, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Centripetal Networks, Inc. v. Cisco Systems, Inc. (E.D. Va. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-04-10 387 NW Washington, DC 20005 Tel: (202) 962-7000 Fax: (202) 962-7111 neil.macbride@davispolk.com … Virginia 23218-1122 Telephone: (804) 697-1200 Facsimile: (804) 697-1339 dabney.carr@troutmansanders.com…February 2018 2:18-cv-00094-HCM-LRL 830 Patent Both District Court, E.D. Virginia… INC.’S OBJECTIONS TO ISSUES RAISED AT APRIL 8, 2020 TELEPHONIC CONFERENCE AND MOTION OPPOSING TRIAL…in Cisco’s Objections to Issues Raised at April 8, 2020 Telephonic Conference and Memorandum in Support External link to document
2020-04-10 388 Washington, DC 20005 Tel: (202) 962-7000 Fax: (202) 962-7111 neil.macbride@davispolk.com …Virginia 23218-1122 Telephone: (804) 697-1200 Facsimile: (804) 697-1339 dabney.carr@troutmansanders.com… “’370 Patent”), and 9,917,856 (“the “’856 Patent”). The ’077 Patent and the ’213 Patent have since…this case: the ’205 Patent and the ’856 Patent. Only two of the ten total patent claims asserted in this…the ’856 Patent—overlap with the Keysight trial. The ’205 Patent, meanwhile, is the patent on which External link to document
2020-04-27 411 ,413,722 ("the '722 Patent"); U.S. Patent No. 9,203,806 ("the '806 Patent"…quot;148 Patent"), 9,560,077(the '"077 Patent"), and 9,413,722 (the '"722…the '552 Patent,'713 Patent,'213 Patent,'148 Patent, and '077 Patent, invalidated… the '552 Patent,'713 Patent,'213 Patent,'148 Patent,'077 Patent, and unasserted… Network." 10. The application for the '205 Patent was filed on October 22, 2012 External link to document
2020-05-02 428 two patents that share the identical disclosure and drawings as the ’193 Patent (U.S. Patent Nos. … 9,413,722) on or before May 20, 2020. CISCO…Christopher J. Tyson, VSB No. 81553 DUANE MORRIS, LLP 505 9th Street, N.W., Suite 1000 Washington, DC 20004…Notice of Additional United Stated Patent and Trademark Office (“Patent Office”) Decisions Concerning…, the Patent Office issued a decision to re-examine Asserted Claims 63 and 77 of U.S. Patent No. 9, External link to document
2020-05-21 445 18 and 19 of U.S. Patent No. 9,686,193 (the “’193 patent”). Trial Tr. (Vol. 4) (Mitzenmacher) at 433… Practice Key Limitations of U.S. Patent No. 9,686,193 ......................................… Practice Key Limitations of U.S. Patent No. 9,686,193 Centripetal contends that the…art. Ex. A3 (’806 patent prosecution history, October 6, 2015 Amendment) at 2-4, 6 (amending claims…version 6.10.3. Trial Tr. (Vol. 7A) (Cole) at 996:5-10; PTX-591. Focusing on page 4 of this document External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
McKinsey
Express Scripts
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.